Objective: to explore the influence and effect of diet nursing on decompensation stage of cirrhosis. Methods: 62 patients with decompensated liver cirrhosis treated in our hospital from April 2020 to April 2021 were s...Objective: to explore the influence and effect of diet nursing on decompensation stage of cirrhosis. Methods: 62 patients with decompensated liver cirrhosis treated in our hospital from April 2020 to April 2021 were selected. All patients were given in-hospital nursing intervention. The patients were randomly divided into two groups. 31 cases in the reference group were given routine nursing, and 31 cases in the observation group were given diet nursing on the basis of routine nursing. The liver function indexes (alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol (TB)) and the quality of life (evaluated by SF-36) of the two groups were compared before and after nursing. Results: before nursing, there was no significant difference in ALT, AST, TB levels and SF-36 scores between the two groups (P > 0.05). After nursing, the levels of ALT, AST and TB in the observation group were lower than those in the reference group, and the SF-36 score was higher than that in the reference group. The difference was statistically significant (P < 0.05). Conclusion: in the clinical nursing of patients with decompensated liver cirrhosis, the application of dietary nursing can effectively improve patients' liver function, reduce liver function injury and improve the quality of life. The application value of dietary nursing is significant.展开更多
Objective: to study and analyze the clinical value of Quxie Fushen decoction in the treatment of chronic renal insufficiency of decompensated stage of spleen-kidney yang deficiency. Methods: fifty patients with decomp...Objective: to study and analyze the clinical value of Quxie Fushen decoction in the treatment of chronic renal insufficiency of decompensated stage of spleen-kidney yang deficiency. Methods: fifty patients with decompensated chronic renal insufficiency who were admitted to our hospital from January 2020 to August 2021, all patients with spleen and kidney yang deficiency, were randomly divided into the study group and the control group (each group 25 cases). The control group was given routine treatment for chronic renal insufficiency in decompensated stage, and the study group was given the modified Quxie Fushen decoction at the same time. Results: after treatment, the total effective rate of patients in the study group was higher than that in the control group;the inflammatory indexes such as high-sensitivity C-reactive protein and tumor necrosis factor- α were lower than those in the control group, and the renal function indexes such as serum creatinine and blood urea nitrogen were lower than those in the control group. In the control group, the difference was statistically significant (P<0.05). Conclusion: Quxie Fushen decoction for the treatment of patients with chronic renal insufficiency in the decompensated stage of spleen- kidney yang deficiency is of outstanding value in improving the curative effect, promoting the improvement of inflammatory conditions and improving renal function.展开更多
Objective:To explore the effect of entecavir on patients with decompensated chronic hepatitis B cirrhosis.Methods:From October 2007 to December 2019,100 patients with decompensated chronic hepatitis B cirrhosis who we...Objective:To explore the effect of entecavir on patients with decompensated chronic hepatitis B cirrhosis.Methods:From October 2007 to December 2019,100 patients with decompensated chronic hepatitis B cirrhosis who were treated in our hospital were selected to carry out this study.The clinical data of the patients were analyzed.According to whether entecavir treatment was carried out,100 patients were divided into two groups,50 cases in the control group and 50 cases in the observation group.The control group was treated with conventional drugs,and the observation group was treated with entecavir.Liver function indexes,liver fibrosis indexes,HBV-DNA negative conversion rate and incidence of adverse reactions were compared between the two groups.Results:Compared with the control group,the liver function indexes of the observation group were lower,P<0.05;Compared with the control group,the observation group was better,P<0.05;The negative rate of HBV-DNA in the observation group was lower than that in the control group(P<0.05);There was no difference in the incidence of adverse reactions between the two groups,P>0.05.Conclusion:Entecavir can not only improve the liver function,but also enhance the shortterm treatment effect,without increasing adverse reactions,and has high safety,which is worthy of recommendation.展开更多
文摘Objective: to explore the influence and effect of diet nursing on decompensation stage of cirrhosis. Methods: 62 patients with decompensated liver cirrhosis treated in our hospital from April 2020 to April 2021 were selected. All patients were given in-hospital nursing intervention. The patients were randomly divided into two groups. 31 cases in the reference group were given routine nursing, and 31 cases in the observation group were given diet nursing on the basis of routine nursing. The liver function indexes (alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol (TB)) and the quality of life (evaluated by SF-36) of the two groups were compared before and after nursing. Results: before nursing, there was no significant difference in ALT, AST, TB levels and SF-36 scores between the two groups (P > 0.05). After nursing, the levels of ALT, AST and TB in the observation group were lower than those in the reference group, and the SF-36 score was higher than that in the reference group. The difference was statistically significant (P < 0.05). Conclusion: in the clinical nursing of patients with decompensated liver cirrhosis, the application of dietary nursing can effectively improve patients' liver function, reduce liver function injury and improve the quality of life. The application value of dietary nursing is significant.
文摘Objective: to study and analyze the clinical value of Quxie Fushen decoction in the treatment of chronic renal insufficiency of decompensated stage of spleen-kidney yang deficiency. Methods: fifty patients with decompensated chronic renal insufficiency who were admitted to our hospital from January 2020 to August 2021, all patients with spleen and kidney yang deficiency, were randomly divided into the study group and the control group (each group 25 cases). The control group was given routine treatment for chronic renal insufficiency in decompensated stage, and the study group was given the modified Quxie Fushen decoction at the same time. Results: after treatment, the total effective rate of patients in the study group was higher than that in the control group;the inflammatory indexes such as high-sensitivity C-reactive protein and tumor necrosis factor- α were lower than those in the control group, and the renal function indexes such as serum creatinine and blood urea nitrogen were lower than those in the control group. In the control group, the difference was statistically significant (P<0.05). Conclusion: Quxie Fushen decoction for the treatment of patients with chronic renal insufficiency in the decompensated stage of spleen- kidney yang deficiency is of outstanding value in improving the curative effect, promoting the improvement of inflammatory conditions and improving renal function.
文摘Objective:To explore the effect of entecavir on patients with decompensated chronic hepatitis B cirrhosis.Methods:From October 2007 to December 2019,100 patients with decompensated chronic hepatitis B cirrhosis who were treated in our hospital were selected to carry out this study.The clinical data of the patients were analyzed.According to whether entecavir treatment was carried out,100 patients were divided into two groups,50 cases in the control group and 50 cases in the observation group.The control group was treated with conventional drugs,and the observation group was treated with entecavir.Liver function indexes,liver fibrosis indexes,HBV-DNA negative conversion rate and incidence of adverse reactions were compared between the two groups.Results:Compared with the control group,the liver function indexes of the observation group were lower,P<0.05;Compared with the control group,the observation group was better,P<0.05;The negative rate of HBV-DNA in the observation group was lower than that in the control group(P<0.05);There was no difference in the incidence of adverse reactions between the two groups,P>0.05.Conclusion:Entecavir can not only improve the liver function,but also enhance the shortterm treatment effect,without increasing adverse reactions,and has high safety,which is worthy of recommendation.
